Daily Brief United States: Apple , Micron Technology, Aaon Inc, Academy Sports & Outdoors , Anthropic, Appian Corp, Mastec Inc, Grace Therapeutics, Avis Budget Group and more

• ndia does not have a top-down method for executing a five year plan like China does
• hina’s supply chain is vast and highly competitive, with India unlikely to replicate its success
• hina wants technology transfer to be one-way gate, inhibiting India’s ability to compete
• atrick Magee studied religion before becoming a financial journalist and eventually writing about Apple’s dependence on China

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• Q325 revenues of $9.3 billion, up 15% QoQ and up 37% YoY and $500 million above the guided midpoint. This represented a new quarterly revenue record for the company
• Micron forecasted current quarter revenues of $10.7 billion, up 15% QoQ, with gross margin of 42%, up 300 basis points sequentially
• HBM negotiations for 2026 supply & pricing still ongoing. Could Micron be holding out for a better deal?

• AAON Inc.’s first quarter of 2025 results highlight a mix of positive growth and operational challenges, painting a complex picture for potential investors.
• The company’s core strategic pillars focus on innovation, sustainable growth, and operational excellence, positioning it for long-term advancement.
• This focus is evident in its commitment to developing new products, like heat pumps and data center cooling solutions, which align with its innovative goals.

• Results and Guidance beat, driven by HBM very fast growth. HBM also generates higher margins and sucks up DRAM capacity, a secondary benefit. 
• HBM is still in year-2 of a 5-year journey. Industry revenues double in 2025 and Micron HBM revenue increase 5x in FY25. Expect Micron HBM to double in FY26. 
• Consensus is a tad too low for FY26, likely 10% too low. Consensus is very low for FY27, likely 25-30% too low. It’s hard for the sell-side to forecast hyper-growth.

• Academy Sports and Outdoors navigated through a challenging environment in the first quarter of fiscal 2025 marked by new complexities due to newly imposed tariffs and macroeconomic uncertainties.
• Their financial performance for the quarter reported sales of $1.35 billion, slightly down by 0.9% from the previous year, translating to a negative 3.7% in comparable sales.
• Despite unfavorable weather conditions early in the quarter impacting sales, momentum improved towards the end as milder temperatures arrived in March and April, yielding a positive comp in April thanks to strategic initiatives and partnerships.

• Anthropic is a reckless and entitled AI start-up, symbolic of a tech industry that is completely out of control and drunk on its own success.

• A judge in California just ruled that they can use copyrighted data without permission to train their models.

• This allows them to make money of other people’s works without compensating them adequately.

• Appian Corporation reported its financial results for the first quarter of 2025, presenting an optimistic yet complex picture of its ongoing performance.
• The company’s cloud subscription revenue demonstrated a significant increase of 15% year-over-year, amounting to $99.8 million.
• Total subscription revenue rose by 14% to $134.4 million, contributing to an overall revenue growth of 11% year-over-year to $166.4 million.

• MasTec, a diversified infrastructure construction company, reported robust financial performance in the first quarter of 2025, exceeding guidance in key metrics such as revenue, EBITDA, and EPS.
• The company’s revenue stood at $2.85 billion, with adjusted EBITDA of $164 million, marking significant overperformance.
• The strong results came amid macroeconomic volatility, highlighting MasTec’s structural demand strength across its diversified business segments.

• Grace is a clinical-stage, biotechnology company focused on rare disease.
• Its lead program, GTx-104, is a novel injectable formulation of nimodipine for the treatment of aneurysmal subarachnoid hemorrhage (aSAH).
• Other programs include GTX-102 for Ataxia Telangiectasia & GTX-101 for postherpetic neuralgia.

• Avis Budget Group presented a mixed set of results for the first quarter of 2025, revealing substantial challenges alongside strategic advancements.
• The company reported a decline in total revenue to $2.4 billion, compared with $2.5 billion in the same period of the previous year.
• This decline was attributed to calendar shifts and a 2% decrease in pricing, set against softer commercial demand and relatively strong leisure demand.